Basis: Trailing twelve months (TTM). Source: stored company filings and market data; unavailable inputs remain N/A.
The enterprise value (EV) is $149.48M.
ENTERPRISE VALUE (EV)
$149.48M
Upstream Bio, Inc.
Market Cap
$249.79M
Enterprise Value (EV)
$149.48M
| NAME | MARKET CAP | ENTERPRISE VALUE (EV) |
|---|---|---|
| Upstream Bio, Inc. (UPB) | $249.79M | $149.48M |
| CAMP4 Therapeutics Corporation (CAMP)vs › | $248.50M | $163.75M |
| Galectin Therapeutics Inc. (GALT)vs › | $247.62M | $372.05M |
| Sol-Gel Technologies Ltd. (SLGL)vs › | $247.27M | $231.37M |
| Anika Therapeutics, Inc. (ANIK)vs › | $255.88M | $240.79M |
| AC Immune S.A. (ACIU)vs › | $256.47M | $227.21M |
| Lifecore Biomedical, Inc. (LFCR)vs › | $241.94M | N/A |
| Q32 Bio Inc. (QTTB)vs › | $241.39M | $140.41M |
| Quantum-Si incorporated (QSI)vs › | $241.34M | $220.94M |
| Palisade Bio, Inc. (PALI)vs › | $258.63M | $133.46M |
Market Cap
$249.79M
Total Debt
$1.27M
Cash
$101.58M
Enterprise Value
$149.48M
Why use EV instead of Market Cap?
Enterprise Value represents the total value of a company as if you were to acquire it completely - paying for equity while assuming debt and receiving cash.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
